The Traderszone Network

The changing climate is everywhere Gustavo Carranza looks when he walks through his undulating citrus farm here in this tiny town in the foothills of the Sierra Nevada.

Life science facilities are perhaps the hottest real estate subsector right now, and there are some great ways for investors to get a piece of the action. In this Fool Live video clip, recorded on Sept. 3, Millionacres senior real estate analyst Matt Frankel, CFP, discusses two excellent stocks with large portfolios of life science properties. 

Continue reading

Finding value when the stock market is setting new records tends to be difficult. Investors have to be careful that they are not buying stocks as earnings are peaking. This is often the difference between a value stock and a value trap. Sometimes a stock is cheap because the market is giving the company no credit for a line of business or some sort of asset. The market has beaten up on mortgage real estate investment trust New Residential (NYSE: NRZ) — but it’s not giving the company’s cash-generating operating business enough credit.

read more

Moviegoing will likely always be on many people’s list of of things to do on a night out. But the pandemic decimated the industry in 2020, pushing global revenue down 71%. The need to stay at home drove sales of another popular activity — video games — past movies and music combined. 

Despite the trends, traders became enamored with theater chain AMC Entertainment (NYSE: AMC) earlier this year. A combination of economic recovery and the traders’ motivation to burn those betting against the stock fueled a rally lifting shares 2,000% this year. 

read more

There were a lot of companies that jumped to action last year in the fight against the SARS-CoV-2 virus. Videoconferencing, e-commerce, delivery apps, drug development and diagnostics all prospered. In that latter category, one company proved it has a business model to succeed long after the pandemic ends — assuming it ever does.

read more

More COVID-19 vaccines could be on the way. While hundreds of millions of people around the world have received shots from the vaccines that are already approved or authorized, several other vaccine candidates are currently in late-stage testing. In this Motley Fool Live video, recorded on Sept. 8, Fool contributors Keith Speights and Brian Orelli discuss five stocks to watch that could be winners if those late-stage clinical trials are successful.

read more

Not everyone feels the need to retire a millionaire. But let’s face it — it’s a good goal to have. And while it may seem like the sort of goal you can only achieve if you earn a high salary, the reality is that even average earners can close out their careers with $1 million or more to their name.

If your goal is to retire a millionaire, you’ll need to do a few key things:

read more